Project Grant R61DA065211
Award Date 9/1/26
Completion Date 8/31/27
Dollars Obligated $547K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- The National Institute on Drug Abuse awarded New York University $103,607 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct dissertation research on polysubstance use patterns and their associations with methadone maintenance treatment receipt and discontinuation among people who use drugs in New York State. The research uses a mixed-methods approach guided by the Social Ecological Model to identify latent polysubstance use patterns through urine...
- The National Institute on Drug Abuse awarded New York University $3.359 million on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a comprehensive evaluation of New York State's mobile methadone unit program. The project, titled "NY MOVES: Evaluating the Impact of New York's Methadone Outreach Vehicles," applies a mixed-methods and quasi-experimental design following the RE-AIM framework to assess program reach, effectiveness, adoption,...
- The National Institute on Drug Abuse awarded The Trustees of Columbia University in the City of New York $1,555,130 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop quantitative evidence informing personalized, sequential medication-for-opioid-use-disorder (MOUD) treatment protocols. The research applies data fusion methodology to synthesize data from seven large MOUD trials conducted by the NIDA Clinical Trials Network, generating evidence-based...
- The National Institute on Drug Abuse awarded $709,085 to The Regents of the University of Colorado, doing business as University of Colorado-Denver, on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds an implementation trial testing in-hospital opioid treatment program (OTP) intakes to facilitate linkage from hospitalization to outpatient methadone treatment among patients with opioid use disorder. The study uses a staircase cluster randomized...
- The National Institute on Drug Abuse awarded Yale University $641,138 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a study examining methadone dose-associated risks and outcomes in opioid use disorder treatment, with particular focus on aging adults. The research leverages a national cohort of approximately 54,000 patients receiving care in the Department of Veterans Affairs, derived from the Veterans Aging Cohorts Study's national cohort...
- The National Institute on Drug Abuse awarded the Johns Hopkins University $2,141,865 for Project Grant R01DA064510 on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant funds a mixed-methods study evaluating methadone dispensing in carceral facilities using a new regulatory pathway. In 2024, the Substance Abuse and Mental Health Services Administration clarified that any carceral facility registered with the Drug Enforcement Administration as a...
- The National Institute on Drug Abuse awarded the University of Pittsburgh $945,601 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 30, 2025, for the Personalized Methadone Treatment (PROMOTE) study implementing shared decision making in opioid treatment programs. The project adapts implementation facilitation—a bundle of preparation, implementation, and sustainment strategies—to support systematic shared decision making (SDM) implementation within opioid treatment...
- The National Institute on Drug Abuse awarded New York University $771,043 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a hybrid type II implementation-effectiveness trial of a peer change agent intervention designed to increase pre-exposure prophylaxis and medication for opioid use disorder uptake among people who inject drugs. The study, titled "A Social Network Approach to Improve HIV Prevention and Substance Use Treatment for People Who...
- The National Institute on Drug Abuse awarded Icahn School of Medicine at Mount Sinai $100,228 on October 8, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research on opioid reward mechanisms. The award funds a project investigating the functional role of a novel cortical circuit connecting the dorsal peduncular nucleus to the ventral tegmental area in mediating opioid reward. The research employs barcoded anatomy resolved by sequencing combined with spatial...
- The National Institute on Drug Abuse awarded Johns Hopkins University $198,164 on October 17, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining barriers to medications for opioid use disorder (MOUD) treatment for individuals transitioning from correctional facilities to community settings. The research employs a complex systems approach combining quantitative and qualitative methods. Specific aims include examining the structure and function...